Neutrophil-to-lymphocyte ratio as a prognostic biomarker in lung cancer patients treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis
{{output}}
Lung cancer (LC) continues to be a leading cause of cancer-related mortality, highlighting the need for reliable and accessible biomarkers to identify patients at higher risk of poor outcomes during immunotherapy. This systematic review and meta-analysis aimed... ...
